C
GOSS icon

Covestor’s Gossamer Bio GOSS Stock Holding History

Covestor’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-99
Closed – – 2325
2023
Q2 		$0 Buy
99
+52
+111% +$65 ﹤0.01% 2322
2023
Q1 		$0 Buy
47
+37
+370% +$71 ﹤0.01% 2231
2022
Q4 		$0 Buy
+10
New +$82 ﹤0.01% 2257

Other funds holding GOSS

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Covestor's GOSS Position: Q3 2023 in Review

Covestor sold out of Gossamer Bio (GOSS) in Q3 2023, closing a stake of 99 shares.

Covestor first reported a position in GOSS in Q4 2022 and held it in 3 quarters. The position peaked at $0 in Q2 2023. 95 funds tracked by Wall St. Rank hold GOSS as of Q3 2023.

  • Covestor reported no remaining Gossamer Bio position as of Q3 2023 after selling out during the quarter.
  • Covestor sold 99 Gossamer Bio shares in Q3 2023.
  • Covestor first reported a position in Gossamer Bio in Q4 2022 and held it in 3 quarters.
  • Covestor's Gossamer Bio position peaked at $0 in Q2 2023.
  • 95 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2023.

Based on Covestor's 13F filing for Q3 2023, filed 13 Nov 2023.